Your browser doesn't support javascript.
loading
Advancement and properties of circular RNAs in prostate cancer: An emerging and compelling frontier for discovering.
Zhou, Hong; Zheng, Xu-Dong; Lin, Chang-Ming; Min, Jie; Hu, Shuang; Hu, Ying; Li, Liang-Yun; Chen, Jia-Si; Liu, Yu-Min; Li, Hao-Dong; Meng, Xiao-Ming; Li, Jun; Yang, Ya-Ru; Xu, Tao.
Afiliação
  • Zhou H; Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC West District, University of Science and Technology of China, Hefei 230031, China.
  • Zheng XD; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
  • Lin CM; Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China.
  • Min J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
  • Hu S; Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China.
  • Hu Y; Department of Urology, the Fourth Affiliated Hospital of Anhui Medical University, Hefei, 230011, China.
  • Li LY; Department of Urology, The Second Hospital of Anhui Medical University, Hefei 230601, China.
  • Chen JS; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
  • Liu YM; Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China.
  • Li HD; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
  • Meng XM; Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China.
  • Li J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
  • Yang YR; Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China.
  • Xu T; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
Int J Biol Sci ; 17(2): 651-669, 2021.
Article em En | MEDLINE | ID: mdl-33613119
Prostate cancer (PC) is the most common carcinoma among men worldwide which results in 26% of leading causes of cancer-related death. However, the ideal and effective molecular marker remains elusive. CircRNA, initially observed in plant-infected viruses and Sendai virus in 1979, is generated from pre-mRNA back-splicing and comes in to play by adequate expression. The differential expression in prostate tissues compared with the control reveals the promising capacity in modulating processes including carcinogenesis and metastasis. However, the biological mechanisms of regulatory network in PC needs to systemically concluded. In this review, we enlightened the comprehensive studies on the definite mechanisms of circRNAs affecting tumor progression and metastasis. What's more, we validated the potential clinical application of circRNAs serving as diagnostic and prognostic biomarker. The discussion and analysis in circRNAs will broaden our knowledge of the pathogenesis of PC and further optimize the current therapies against different condition.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma / RNA Circular Limite: Animals / Humans / Male Idioma: En Revista: Int J Biol Sci Assunto da revista: BIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma / RNA Circular Limite: Animals / Humans / Male Idioma: En Revista: Int J Biol Sci Assunto da revista: BIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China